Heramed Limited

HMD.ASX

Health Care

Development, manufacture and distribution of fetal heart beat monitors and other pregnancy-related solutions.

Market Data

Price

$0.040

+0.1%
Market Cap

$42.8M

P/E Ratio

-100000.0x

EPS

$-0.004

Div. Yield

0.00%

52-Week Change

+0.3%

Latest Earnings

Preliminary Final Report

27 February 2026

Revenue
$0.43
-10.3% YoY
NPAT
-$4.13
+24.8% YoY

HeraMED Limited reported a difficult FY2025, with revenues declining 10.3% to $431,605 as the company continues to operate at an early-stage scale. However, the net loss improved significantly by 24.8% to $4.13M (from $5.49M in FY2024), suggesting meaningful cost discipline or reduced cash burn. No dividends were declared, and net tangible assets per share halved from 0.23 cents to 0.11 cents, reflecting ongoing capital consumption. Key points: Net loss improved by 24.8% year-on-year to $4.13M, down from $5.49M in FY2024, indicating meaningful cost reduction or improved operational efficiency; Unmodified (clean) audit opinion issued for FY2025, providing assurance on financial statement integrity; Loss reduction of approximately $1.36M demonstrates management's focus on reducing cash burn

Recent Announcements

27 Feb 2026 Actual Results Negative

Preliminary Final Report

HeraMED Limited reported a difficult FY2025, with revenues declining 10.3% to $431,605 as the company continues to operate at an early-stage scale. However, the net loss improved significantly by 24.8% to $4.13M (from $5.49M in FY2024), suggesting meaningful cost discipline or reduced cash burn. No dividends were declared, and net tangible assets per share halved from 0.23 cents to 0.11 cents, reflecting ongoing capital consumption. Key points: Net loss improved by 24.8% year-on-year to $4.13M, down from $5.49M in FY2024, indicating meaningful cost reduction or improved operational efficiency; Unmodified (clean) audit opinion issued for FY2025, providing assurance on financial statement integrity; Loss reduction of approximately $1.36M demonstrates management's focus on reducing cash burn

Get real-time alerts for HMD

Receive AI-powered earnings summaries and instant notifications when Heramed Limited releases results.

Register Free